Alzheimer's Society
Jump to: content Jump to: navigation   Accessibility Contact Us Mobile Shop

Go to Graphical version

 

Alzheimer's Society comment on work at the University of Chester into homocysteine and vitamins

Published 1 February 2008

People with dementia, including Alzheimer’s disease and vascular disease have been shown to have higher levels of homocysteine, in some population studies.

The molecule is carried by everyone, but those who go on to develop some dementias appear to have higher levels of the compound.
 
Experiments at the University of Chester suggest a new vitamin complex appears to break down homocysteine faster than the vitamin folate. Clinical trials must be carried out before it can be recommended for more general use.
Research is also needed to establish just what role if any homocysteine plays in the development of dementia and how best to keep levels of the molecule low.

Dr Susanne Sorensen
Head of research
Alzheimer's Society 

Note to editors:

  • The Alzheimer's Society is the leading care and research charity for people with all forms dementia and their carers. It provides information and education, support for carers, and quality day and home care. It funds medical and scientific research and campaigns for improved health and social services and greater public understanding of dementia. 
  • The Alzheimer's Society provides a national help line on 0845 3000 336 and website http://www.alzheimers.org.uk/. Please include this information in any publication that uses these comments.

For more information contact: Press office (0207 423 3595)